TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
SVAR Life Science AB
Closing information (x1000 NOK)
| Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Turnover |
251,412
|
216,395
|
216,195 |
| Financial expenses |
7,660
|
6,708
|
14,110 |
| Earnings before taxes |
42,809
|
-34,325
|
-7,903 |
| EBITDA |
45,196
|
37,811
|
-4,283 |
| Total assets |
264,641
|
237,596
|
301,859 |
| Current assets |
164,580
|
100,344
|
92,561 |
| Current liabilities |
55,558
|
50,413
|
64,213 |
| Equity capital |
184,143
|
146,995
|
180,200 |
| - share capital |
277
|
286
|
307 |
| Employees (average) |
120
|
123
|
90 |
Financial ratios
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Solvency |
69.6%
|
61.9%
|
59.7% |
| Turnover per employee |
2,095
|
1,759
|
2,402 |
| Profit as a percentage of turnover |
17.0%
|
-15.9%
|
-3.7% |
| Return on assets (ROA) |
19.1%
|
-11.6%
|
2.1% |
| Current ratio |
296.2%
|
199.0%
|
144.1% |
| Return on equity (ROE) |
23.2%
|
-23.4%
|
-4.4% |
| Change turnover |
41,521
|
15,137
|
-48,328 |
| Change turnover % |
20%
|
8%
|
-18% |
| Chg. No. of employees |
-3
|
33
|
-40 |
| Chg. No. of employees % |
-2%
|
37%
|
-31% |
Total value of public sale
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.